NGGT Inc.
PrivateLast Round
Series B
Jul 11, 2023
Total Funding Raised
$70M
Company Overview
NGGT Inc. is a biotechnology company that develops gene therapies for the treatment of rare genetic diseases, including retinal, metabolic, and neurodegenerative disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NGGT Inc. Comparables
Compare NGGT Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Capsida Biotherapeutics | 81% | |
| Vivet Therapeutics | 80% | |
| Beacon Therapeutics | 76% |
NGGT Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jul 11, 2023 | ||||
| Series A | Apr 15, 2021 | ||||
| Angel | Jul 1, 2020 |
NGGT Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Shanghai Healthcare Capital | Series B |
| YuanBio Venture Capital | Angel, Series A |
| Northern Light Venture Capital | Angel, Series B, Series A |
| 德同资本 | Series B |
| Infinity Group | Series B |
NGGT Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about NGGT Inc.'s valuation, stock price, and market status.
Is NGGT a public or private company?
NGGT is a private company.
What is the current stock price of NGGT?
NGGT is a private company with no public stock price. No recent secondary market data is available.
How much is NGGT worth (valuation)?
Valuation information for NGGT is not publicly available.
Can I buy NGGT stock?
NGGT shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was NGGT's last funding round?
NGGT's most recent funding round was Series B on July 11, 2023.
Who are the main investors in NGGT?
Key investors in NGGT include Shanghai Healthcare Capital.
Will NGGT IPO soon?
No public IPO plans have been announced for NGGT.
How can I track NGGT secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NGGT's secondary market activity and sign up for updates.